PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tiny RNA shown to cause multiple types of leukemia

2010-11-30
(Press-News.org) CAMBRIDGE, Mass. (November 29, 2010) – Whitehead Institute researchers have shown in mouse models that overexpression of the microRNA 125b (miR-125b) can independently cause leukemia and accelerate the disease's progression. Their results are published in this week's online edition of the Proceedings of the National Academy of Sciences (PNAS).

"MicroRNAs are elevated in many cancers, but in humans and mice, can upregulation of a microRNA actually cause the cancer? That's the question," says Whitehead Institute Founding Member Harvey Lodish. "This 22 nucleotide RNA, one of the smallest RNAs in the body, apparently causes leukemia when it's overexpressed."

According to estimates from the National Cancer Institute, more than 43,000 people in the United States will be diagnosed with some form of leukemia in 2010 and approximately 22,000 will die from the disease. In leukemia, one type of blood cell divides in an uncontrolled fashion in the bone marrow, crowding out other blood cells and frequently causing lowered immunity, anemia, and organ damage.

Leukemias are differentiated by the cell type that hyperproliferates, be it a cell from the lymphoid lineage (B or T-cell) or the myeloid lineage that give rise to red cells, platelets or myeloid cells.

Like other cancers, leukemia is caused by genetic mutations that alter how cells divide, proliferate, or mature. Some leukemia-causing mutations, like the BCR-ABL gene fusion, are relatively well-studied, but little is known about many leukemia-causing mutations.

In the PNAS paper, first author Marina Bousquet examined a less-studied mutation that leads to miR-125b overexpression in some leukemia patients.

MicroRNAs, like miR-125b, are very short pieces of RNA that normally fine-tune the activity of their target genes. Some miR-125b targets have already been described, including genes involved in the P53 pathway. These targets, which were found by Lodish's former graduate student, Minh Le, are involved with programmed cell death (apoptosis).

Mutations can cause this fine-tuning mechanism to malfunction. In the case of the mutation studied by Bousquet, miR-125b is cranked up to 90 times its normal expression.

To see if this overexpression could actually cause leukemia on its own, Bousquet injected into mice fetal liver cells that overexpressed miR-125b. After 16 weeks, the mice showed extremely high miR-125b production. Between 12 and 29 weeks after the transplantation, half of the mice died from one of three types of leukemia: myeloproliferative neoplasm, B-cell acute lymphoblastic leukemia, or T-cell acute lymphoblastic leukemia.

"Because miR-125b can lead to different kinds of leukemia, it's a major cancer-causing miR," says Bousquet. "It's also interesting that overexpression of miR-125b is seen in patients with B-cell lymphoblastic leukemia and myeloid leukemia, so I'm pretty sure we can find overexpression in other leukemias."

After establishing that miR-125b overexpression can cause different leukemias, Bousquet tested whether miR-125b overexpression can also accelerate disease progression. Into mice without any bone marrow, she transplanted bone marrow cells that had either the BCR-ABL mutation or the BCR-ABL mutation with a miR-125b overproduction mutation. The mice with both mutations had a median survival of 21 days, compared with 35 days for the BCR-ABL-only control group, a statistically significant difference.

The two experiments show that miR-125b overexpression can be both the primary cause for leukemia and be a secondary agent that hastens its progression.

Although many of miR-125b's target genes have not yet been identified, Bousquet says they are probably involved in proliferation, and cell maturation.

"This is the problem with microRNAs – each miR has many targets," says Bousquet, who will be investigating these targets further. "I would say there is not one good target, but I assume I will find a combination of targets."

Once identified, Bousquet hopes that miR-125b or its gene targets could be exploited therapeutically. Lodish, however remains skeptical.

"We know that miR-125b could trigger leukemia," says Lodish. "But what we don't know is once the cancer has progressed, whether you still need miR-125b. If established leukemia doesn't require miR-125b overexpression, then targeting the microRNA would have little effect."

###This research was supported by the Leukemia and Lymphoma Foundation, Association pour la Recherche sur le Cancer (ARC), and the National Institutes of Health (NIH).

Harvey Lodish's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology and a professor of bioengineering at Massachusetts Institute of Technology.

Full Citations:

"MicroRNA miR-125b causes leukemia"
PNAS, online the week of November 29, 2010.
Marina Bousquet (1), Marian H. Harris (2), Beiyan Zhou (1,3), Harvey Lodish (1, 4). 1. Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142
2. Department of Pathology, Children's Hospital Boston, Boston, MA, 02115
3. Present address: Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843
4. Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02138

END



ELSE PRESS RELEASES FROM THIS DATE:

Ancient wind held secret of life and death

Ancient wind held secret of life and death
2010-11-30
The mystery of how an abundance of fossils have been marvellously preserved for nearly half a billion years in a remote region of Africa has been solved by a team of geologists from the University of Leicester's Department of Geology. They have established that an ancient wind brought life to the region – and was then instrumental in the preservation of the dead. Sarah Gabbott, Jan Zalasiewicz and colleagues investigated a site near the Table Mountains in South Africa. Their findings are published in the latest issue of the journal Geology. Sarah Gabbott said: "Near ...

Soil microbes define dangerous rates of climate change

2010-11-30
The rate of global warming could lead to a rapid release of carbon from peatlands that would further accelerate global warming. Two recent studies published by the Mathematics Research Institute at the University of Exeter highlight the risk that this 'compost bomb' instability could pose, and calculate the conditions under which it could occur. The same Exeter team is now exploring a possible link between the theories described in the studies and last summer's devastating peatland fires in Russia. The first paper is published in the European Journal of Social Science ...

Air above Dead Sea contains very high levels of oxidized mercury

Air above Dead Sea contains very high levels of oxidized mercury
2010-11-30
Measurements show that the sea's salt has profound effects on the chemistry of the air above its surface. The atmosphere over the Dead Sea, researchers have found, is laden with oxidized mercury. Some of the highest levels of oxidized mercury ever observed outside the polar regions exist there. The results appear in a paper published on-line November 28th in the journal Nature Geoscience. In the research, funded by the National Science Foundation (NSF), scientist Daniel Obrist and colleagues at the Desert Research Institute in Reno, Nevada, and at Hebrew University ...

How to soften a diamond

How to soften a diamond
2010-11-30
It is the hardest material in the world, and yet it can not only be used to cut other materials, but can be machined itself. Already over 600 years ago first diamonds were cut and the same technique is still used to transform precious stones into exquisite jewelry and later into unrivaled industrial tools. Dr. Lars Pastewka's and Prof. Michael Moseler's team at the Fraunhofer Institute for Mechanics of Materials IWM in Freiburg/Germany can now reveal the secret of why it is that diamonds can be machined. The team published its findings in the current online issue of Nature ...

Male reproductive problems may add to falling fertility rates

2010-11-30
Paris, 29 November 2010 – Reduced male fertility may be making it even harder for couples to conceive and be contributing to low birth rates in many countries, reveals a new European Science Foundation (ESF) report launching today. More than 10% of couples worldwide are infertile, contributing to the growing demand for assisted reproduction techniques such as in vitro fertilisation (IVF) for which Robert G. Edwards won the Nobel Prize in Medicine last month. Sperm counts have dropped significantly in the last 50 years in developed countries. Today, at least one in ...

Neurological protein may hold the key to new treatments for depression

2010-11-30
For Immediate Release – November 29, 2010 (Toronto) – Neuroscientists at the Centre for Addiction and Mental Health (CAMH) have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression affects one in ten Canadians at some time in their lives and is a leading cause of disability worldwide. The study published in this month's Nature Medicine found that coupling between two dopamine receptors was significantly elevated in the brains of people who had been diagnosed with major depression. ...

Subsurface scattering in point-based rendering

2010-11-30
The Department of Computer Engineering, Sejong University in Korea and ETH Zurich in Switzerland have recently introduced a novel and simple framework for rendering subsurface scattering on surfaces represented by points. This is useful for realistically rendering a cloud of points representing translucent materials such as the human skin. This significant study is reported in Vol. 53, No. 5 of SCIENCE CHINA Information Sciences. The point-based graphics method for rendering surfaces has gained much attention as an alternative to polygon-based graphic methods because ...

Bird-brained? Birds' personalities are correlated with their hormone levels

2010-11-30
The Great Tit is a common garden bird of many countries in Europe and Asia. Great Tits are generally thought of as fairly inquisitive but it has long been known individuals vary considerably in their willingness to explore new surroundings. Some birds – known as "fast" or "proactive" – are quick explorers and are comparatively aggressive, whereas "slow" or "reactive" birds are more cautious. The differences are at least in part genetically determined and as a result scientists in Holland, with whom the Vienna group has been collaborating closely, have been able to use ...

More lives saved with 24/7 enhanced staffing in medical ICU

2010-11-30
In a first-of-its-kind study to measure the impact of the highest recommended specialist staffing levels in an intensive care unit, researchers at the University of Maryland School of Medicine found that increased staffing by specially trained physicians and other health care professionals can enhance patient survival and enable patients to breathe sooner without assistance. The results of the study have been released online ahead of print in the journal Critical Care Medicine. The researchers analyzed the files of patients in the Medical Intensive Care Unit (MICU) ...

Fire forecast technology could help rescue teams save lives

2010-11-30
Fires in homes and offices could be tackled more efficiently using technology that predicts how a blaze will spread. A new technique is able to feed data taken from sensors located in burning buildings into computer models so that rescue services can predict how fires will spread. The technology could save firefighters valuable time by giving several minutes of warning on how a fire will develop, helping them to contain the blaze and minimise its impact. Simple sensors – incorporated into smoke alarms, room temperature sensors or CCTV cameras – can measure the temperature ...

LAST 30 PRESS RELEASES:

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

Setting the stage for the “Frankfurt Alliance”

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Tiny RNA shown to cause multiple types of leukemia